Start Date
Immediate
Expiry Date
17 Sep, 25
Salary
0.0
Posted On
07 Aug, 25
Experience
0 year(s) or above
Remote Job
Yes
Telecommute
Yes
Sponsor Visa
No
Skills
Assessment, Animal Handling, Gene Therapy, Biomedical Engineering, Inflammation, Research Ethics, Immunology, Immunohistochemistry, Materials Science, Publications
Industry
Pharmaceuticals
Department: Department of Anatomy and Regenerative Medicine
Reporting to: Dr Eamon Sheehy & Prof Fergal O’Brien
Location: Tissue Engineering Research Group, Royal College of Surgeons in Ireland, 123 St Stephens Green, Dublin 2
Contract/Duration Full-time, Specified purpose contract up to 12 months
Remuneration: Salary is according to Research Ireland salary scales and is dependent on experience
Closing Date: 18th of August
RCSI is a community of academic, research, clinical and professional staff working collaboratively to lead the world to better health. Here, you will thrive in an innovative and inclusive atmosphere and your personal development and wellbeing will be supported. We invite you to join us to help deliver on our exciting mission “To educate, nurture and discover for the benefit of human health”. We seek candidates whose experience to date has prepared them to contribute to our commitment to the “Race Equality Action Plan 2025-2029” at RCSI. Our students come from all walks of life and so do we. We hire great people from a wide variety of backgrounds. This makes our university stronger and ensures we hire the best talent.
Innovating for a Healthier Future 2023-2027 is RCSI’s new five-year strategic plan. Through it, RCSI will enhance human health by meeting the health workforce needs of society, creating the insights and inventions that drive health improvements, and working in partnership with patients and the public in support of better health and well-being for all. The strategy unites the RCSI community in supporting the UN Sustainable Development Goals – with a particular focus on Goal 3, which targets good health and well-being.
For each of the last six years, RCSI has been positioned in the Top 300 of universities worldwide in the Times Higher World University Rankings. We are proud that RCSI ranks fifth in the world for “Good Health and Well-being” in the Times Higher Education #SDG #SDG Impact Rankings 2024. This reflects our commitment to supporting people of all ages to live healthy lives and our work to promote the concepts of well-being and positive health. In 2024, RCSI was delighted to be named one of the Sunday Times Best Places to Work in Ireland.
At RCSI, our core values of Respect, Collaboration, Scholarship, and Innovation are at the heart of everything we do. We are committed to creating an inclusive and supportive environment where every colleague is valued and empowered to thrive. Our dedication to these values ensures that we foster a culture of mutual respect, open collaboration, continuous learning, and innovative thinking. Join us at RCSI, where your contributions will be recognised, and you will be part of a dynamic team making a real impact on global health.
SUMMARY OF POST
This project targets the development of an advanced therapy medical product (ATMP) comprising a 3D-printed gene-activated scaffold for cartilage regeneration. The project aims to reinforce highly porous multi-layered collagen-based scaffolds with 3D-printed polycaprolactone frameworks and to functionalise these reinforced scaffolds with therapeutic genetic cargos in order to ameliorate joint inflammation and promote hyaline cartilage formation. The role is part an RCSI-managed, Research Ireland Accelerating Research to Commercialization (ARC) – Therapeutics Hub project which is co-funded through EU Regional Development funding. Successful candidates will join a multidisciplinary team in Prof Fergal O’Brien’s Tissue Engineering Research Group. The project will involve development of a working prototype of the ATMP and validation through in vitro and in vivo testing while contributing to commercialization activities (e.g. business plan development) and IP applications. Training courses in entrepreneurship will be available through the ARC Hub. The project will combine aspects of additive manufacturing, scaffold fabrication, tissue engineering and gene therapy. We are looking for candidates with experience in tissue engineering, material science, genetics or immunology. Experience in chondrogenic tissue culture, animal handling, 3D-printing or gene therapy is highly desirable.
QUALIFICATIONS – (ESSENTIAL):
Knowledge & Experience – (Essential):
Knowledge & Experience – (Desirable):